STAAR Surgical Company Insiders

STAA Stock  USD 15.35  0.61  3.82%   
STAAR Surgical's insiders are aggressively buying. The analysis of insiders' sentiment of trading STAAR Surgical stock suggests that vertually all insiders are extremely bullish at this time. STAAR Surgical employs about 16 people. The company is managed by 16 executives with a total tenure of roughly 58 years, averaging almost 3.0 years of service per executive, having 1.0 employees per reported executive.
Caren Mason  Chairman
CEO and President Director and Chairman of Quality and Regulatory Committee
HansMartin Blickensdoerfer  President
President International Commercial Operations

Insider Sentiment 100

 Aggressively Buying

 
Selling
 
Buying

Latest Trades

2025-02-14Broadwood Partners, L.P.Acquired 36532 @ 15.49View
2025-02-12Broadwood Partners, L.P.Acquired 259616 @ 14.96View
2025-01-16Broadwood Partners, L.P.Acquired 8221 @ 21.5View
2025-01-14Broadwood Partners, L.P.Acquired 21155 @ 21.46View
2024-12-18Broadwood Partners, L.P.Acquired 23000 @ 24.33View
2024-12-16Broadwood Partners, L.P.Acquired 53500 @ 24.24View
2024-08-12Arthur C ButcherAcquired 1315 @ 37.99View
2024-05-09Broadwood Partners, L.P.Acquired 1 @ 42.56View
2024-03-14Aimee S WeisnerAcquired 1750 @ 38.11View
Monitoring STAAR Surgical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.

STAAR Surgical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with STAAR Surgical's future performance. Based on our forecasts, it is anticipated that STAAR will maintain a workforce of about 230 employees by March 2025.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

STAAR Surgical Management Team Effectiveness

The company has return on total asset (ROA) of (0.0158) % which means that it has lost $0.0158 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0516) %, meaning that it created substantial loss on money invested by shareholders. STAAR Surgical's management efficiency ratios could be used to measure how well STAAR Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.11. At present, STAAR Surgical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 149 M, whereas Non Currrent Assets Other are forecasted to decline to about 1.8 M.
The current year's Net Income Applicable To Common Shares is expected to grow to about 46.8 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 29.4 M.

STAAR Surgical Workforce Comparison

STAAR Surgical is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 146,022. STAAR Surgical adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.

STAAR Surgical Profit Margins

The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.57.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.490.7751
Way Down
Very volatile

STAAR Surgical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STAAR Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on STAAR Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, STAAR Surgical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2025-03-01
14.0
14
1
 440,806 
 10,775 
2024-06-01
6.5
13
2
 35,759 
 4,088 
2024-03-01
26.0
26
1
 541,276 
 10,739 
2023-09-01
18.0
18
1
 492,614 
 2,539 
2023-06-01
6.0
12
2
 125,783 
 2,488 
2023-03-01
1.25
20
16
 426,216 
 22,497 
2022-09-01
0.5
2
4
 13,770 
 44,399 
2022-06-01
2.375
19
8
 244,151 
 179,961 
2022-03-01
2.8
14
5
 235,983 
 30,374 
2021-12-01
0.125
1
8
 35,000 
 196,000 
2021-09-01
0.6296
17
27
 143,771 
 284,921 
2021-06-01
0.4675
36
77
 265,294 
 1,412,491 
2021-03-01
0.5147
35
68
 244,877 
 1,678,698 
2020-12-01
0.5417
13
24
 130,528 
 288,578 
2020-09-01
1.0
16
16
 145,814 
 355,450 
2020-06-01
0.9655
28
29
 397,889 
 594,458 
2020-03-01
1.1905
25
21
 435,732 
 326,622 
2019-12-01
0.5714
8
14
 125,211 
 216,730 
2019-06-01
0.8889
8
9
 130,939 
 45,468 
2019-03-01
0.5556
5
9
 222,097 
 66,730 
2018-06-01
5.3333
16
3
 226,457 
 51,662 
2018-03-01
1.25
10
8
 162,031 
 71,796 
2017-12-01
1.0
1
1
 12,500 
 6,000 
2017-06-01
3.0
6
2
 60,516 
 9,000 
2017-03-01
1.1429
8
7
 335,000 
 66,283 
2016-12-01
0.5
2
4
 25,000 
 50,000 
2016-09-01
5.0
5
1
 32,761 
 50,000 
2016-06-01
4.8
24
5
 512,888 
 50,000 
2016-03-01
15.0
60
4
 2,676,391 
 50,016 
2015-06-01
1.0909
12
11
 828,486 
 183,223 
2015-03-01
0.5
1
2
 400,000 
 13,253 
2014-06-01
14.0
14
1
 126,500 
 2,800 
2014-03-01
1.8
18
10
 216,241 
 102,934 
2013-12-01
0.4286
3
7
 710,000 
 254,544 
2013-09-01
0.2903
9
31
 104,315 
 285,413 
2013-06-01
2.6667
8
3
 80,600 
 105,000 
2013-03-01
19.0
19
1
 276,697 
 20,000 
2012-12-01
4.5
9
2
 41,790 
 53,000 
2012-09-01
2.2
11
5
 338,385 
 45,334 
2012-06-01
1.4167
17
12
 128,666 
 83,132 
2012-03-01
0.4524
19
42
 275,100 
 25,100 
2011-12-01
0.0571
2
35
 10,000 
 74,000 
2011-09-01
0.3492
22
63
 164,134 
 239,510 
2011-06-01
1.0
10
10
 167,500 
 146,334 
2011-03-01
1.6471
28
17
 311,100 
 3,900 
2010-12-01
1.5
6
4
 166,666 
 43,468 
2009-09-01
0.625
5
8
 23,000 
 47,766 
2009-06-01
0.6667
6
9
 1,239,362 
 200,000 
2008-06-01
10.0
50
5
 229,850 
 21,850 
2007-12-01
56.0
56
1
 1,565,437 
 5,000 
2007-09-01
146.0
146
1
 503,722 
 50,000 
2007-06-01
0.9474
18
19
 592,605 
 131,677 
2007-03-01
4.0
4
1
 25,926 
 70,000 
2006-12-01
0.0763
9
118
 72,200 
 196,900 
2006-09-01
0.129
4
31
 58,000 
 109,854 
2006-06-01
0.3571
5
14
 118,000 
 91,000 
2005-09-01
0.4
4
10
 70,000 
 10,000 
2005-03-01
1.0
1
1
 45,000 
 45,000 
2003-09-01
0.5
1
2
 12,000 
 24,000 

STAAR Surgical Notable Stakeholders

A STAAR Surgical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as STAAR Surgical often face trade-offs trying to please all of them. STAAR Surgical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting STAAR Surgical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thomas FrinziCEO PresidentProfile
Caren MasonCEO and President Director and Chairman of Quality and Regulatory CommitteeProfile
HansMartin BlickensdoerferPresident International Commercial OperationsProfile
Samuel GestenVice President General Counsel, Corporate Compliance Officer and SecretaryProfile
Keith HollidayVice President - Research & DevelopmentProfile
Philippe SubrinVice President - Switzerland OperationsProfile
James FranceseVP of Global MarketingProfile
Nancy SabinChief OfficerProfile
Brian MooreIR Contact OfficerProfile
Warren FoustChief OfficerProfile
Joanne EgaminoGlobal OperationsProfile
Patrick WilliamsChief OfficerProfile
Robert StudholmeSenior OperationsProfile
Scott MDChief OfficerProfile
Nathaniel EsqGeneral SecretaryProfile
Magda MichnaRegulatory ClinicalProfile

About STAAR Surgical Management Performance

The success or failure of an entity such as STAAR Surgical often depends on how effective the management is. STAAR Surgical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of STAAR management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the STAAR management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.07  0.08 
Return On Capital Employed 0.10  0.11 
Return On Assets 0.07  0.08 
Return On Equity 0.10  0.10 
Please note, the presentation of STAAR Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.

STAAR Surgical Workforce Analysis

Traditionally, organizations such as STAAR Surgical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare STAAR Surgical within its industry.

STAAR Surgical Manpower Efficiency

Return on STAAR Surgical Manpower

Revenue Per Employee19.6K
Revenue Per Executive19.6K
Net Loss Per Employee1.3K
Net Loss Per Executive1.3K
Working Capital Per Employee18.8M
Working Capital Per Executive18.8M

Complementary Tools for STAAR Stock analysis

When running STAAR Surgical's price analysis, check to measure STAAR Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STAAR Surgical is operating at the current time. Most of STAAR Surgical's value examination focuses on studying past and present price action to predict the probability of STAAR Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STAAR Surgical's price. Additionally, you may evaluate how the addition of STAAR Surgical to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon